Recap: 2016 Mintz/ML Strategies Pharmacy Industry Summit

By Theresa C. Carnegie

The pharmacy industry is under increasing scrutiny from all angles. Whether at the legislative or agency level, Washington as well as many states seem intent on addressing perceived issues surrounding drug pricing, reimbursement, and program integrity. For these reasons, Mintz and ML Strategies brought together stakeholders and thought leaders from across the industry to share knowledge and insight on this rapidly shifting landscape at the 2016 Mintz/ML Strategies Pharmacy Industry Summit in Washington, DC on May 10.

As drug pricing was a common thread throughout the Summit, those in the pharmacy industry may be interested in a recent ML Strategies White Paper "Transparency in Drug Pricing: Issues to Consider from the Research Lab to the Consumer."

Here’s some of the #MLPharma Twitter buzz:

https://twitter.com/dorothyhoffman/status/730049423250706432
https://twitter.com/RodneyMLS/status/730117031622791169
https://twitter.com/MLStrategies/status/730125029090828288
https://twitter.com/ThinkAnthem/status/730057423784947713
https://twitter.com/mocowan/status/729863834496737280
https://twitter.com/MintzLevin/status/730124312464654336
https://twitter.com/Bianca_MPH/status/730026322421026816
https://twitter.com/eligreenspan/status/730026624205393923

See you next year in DC!

Subscribe To Viewpoints

Published

Viewpoint Topics

Professionals

Author

Theresa C. Carnegie

Member

Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.